PTHL (ftzy.com.cn) Future Price to Earnings

Official company branding of Pheton Holdings (PTHL)

Leadership in the Chinese radiotherapy sector drives the price action on the GURU.Markets chart, where the forward P/E of Pheton Holdings Ltd (PTHL) has reached 0.00, representing the current level of the metric. Growth is based on scalable, high-margin SaaS software for brachytherapy. Business stability is supported by diversified component supplies for laser equipment, which eliminate logistical disruptions.

Pheton Holdings Ltd - PTHL Market Cap to Future Earnings Ratio (period 09/06/2024 - 01/16/2026)

Summary analytical data breakdowns for ftzy.com.cn (PTHL)

- current price and projected stock value:
Fundamental valuation:PTHL Pheton Holdings Limited
Brand item of Pheton Holdings Ltd

Forward P/E determines the share price relative to projected annual earnings, allowing for an assessment of whether an asset is overvalued or undervalued. By analyzing changes in the forward P/E of Pheton Holdings Ltd (PTHL), investors can gauge market expectations, where a high multiple is justified by the expansion of brachytherapy systems and the potential for earnings growth driven by the implementation of innovative oncology treatment methods in China.

Competitor analysis for Pheton Holdings Ltd

Future Price to Earnings haleon.com (HLN)|KVUE (Kenvue Health) - Future Price to Earnings Multiple|Future Price to Earnings Verona Pharma PLC VRNA|Jyong Biotech (MENS) - Projected Price to Earnings Ratio|LGND: Projected Price to Earnings|Amneal - Market Cap to Future Earnings Ratio|PRGO: Forward P/E Multiple|Alvotech Corp - Future Price to Earnings Multiple|LQDA (Liquidia Corp) - Forward P/E Multiple|Projected Price to Earnings Ratio glpg.com GLPG|Future Price to Earnings ANI Pharmaceuticals, Inc. (ANIP)|MNKD (MannKind Corp) - Future Price to Earnings Multiple|Forward P/E Multiple AMPH (Amphastar Pharmaceuticals Inc)|PCRX (Pacira) - Price to Expected Earnings Ratio|SPRY - Future Price to Earnings|Future Price to Earnings Multiple TBPH (Theravance Biopharma)|AQST (aquestive.com) - Projected Price to Earnings|Price to Expected Earnings Ratio SCPH (scPharmaceuticals, Inc.)|Projected Price to Earnings TECX|Tonix Pharmaceuticals (TNXP) - Market Cap to Projected Earnings|Forward P/E Multiple SXTC|Forward P/E Multiple Eupraxia Pharma (EPRX)|Future Price to Earnings BioHarvest Sciences Inc. BHST|EXOZ - Projected Price to Earnings|ORMP: Projected Price to Earnings|Future Price to Earnings Multiple ENTX (enterabio.com)|MindWalk Therapeutics (HYFT) - Future Price to Earnings|Projected Price to Earnings Ratio abvcpharma.com (ABVC)|Future Price to Earnings Cumberland Pharma|Future Price to Earnings QNTM|Forward P/E Multiple FGEN|TELO (Telomir Pharma) - Future Price to Earnings Multiple|Future Price to Earnings Rani Therapeutics Holdings RANI|SNYR - Projected Price to Earnings|RLYB - Future Price to Earnings|Market Cap to Projected Earnings lexariabioscience.com LEXX|PULM: Forward P/E Multiple|Aptorum - Future Price to Earnings Multiple|Projected Price to Earnings LYRA|Projected Price to Earnings Impact BioMedical Inc (IBO)|Forward P/E Multiple TNFA|YCBD: Price to Expected Earnings Ratio|Future Price to Earnings PainReform PRFX|altamiratherapeutics.com (CYTO) - Projected Price to Earnings Ratio|LIPO: Projected Price to Earnings|OPTN (optinose.com) - Price to Future Earnings Ratio|PIRS: Forward P/E Multiple|PROC - Market Cap to Projected Earnings|PTPI (Petros Pharma) - Forward P/E Multiple|Future Price to Earnings QLI|Forward P/E Multiple SLRN|Market Cap to Future Earnings Ratio TFFP